Medical technology company Respiri has chosen Adelaide’s Entech Electronics as its global manufacturing partner for its Wheezo devices to monitor wheezing and breathing in asthma sufferers.
The device is the world’s first digital wheeze monitoring solution of sensor, smartphone application and digital health platform to help people manage respiratory disease.
Wheezo has TGA and CE Mark approvals to go to market.
Respiri, which used Victorian miniaturised electronics manufacturer SRX Global to make pre-commercial quantities of the device, has selected Entech because it is a ‘globally competitive location’.
However manufacture of an initial 12,000 devices will take place in Entech’s facility in Shenzen, China.
The company told investors this would ‘significantly improve product cost through design and bill of material optimisation as well as reductions in labour rates and assembly and test proceedures.’
The ‘cost of goods’ had been cut by 85 per cent with the decision.
Subscribe to our free @AuManufacturing newsletter here.